Swiss Industry Body Urges US Pharma Tariff Negotiations
Swiss pharma group interpharma says US tariffs on medicines will harm patients. It urged the government to seek a trade deal similar to the British agreement.
Xurve View
Insights:
Xurve View
Switzerland's pharmaceutical industry association, Interpharma, has warned that the 100% tariffs imposed by the United States on the pharmaceutical sector threaten global production and supply chains. The industry body stated that these measures would ultimately harm patients and urged the government of Switzerland to negotiate a trade deal similar to the one recently secured by the United Kingdom.
